Open Access iconOpen Access

REVIEW

crossmark

Deciphering resistance mechanisms and novel strategies to overcome drug resistance in ovarian cancer: a comprehensive review

EFFAT ALEMZADEH1, LEILA ALLAHQOLI2, AFROOZ MAZIDIMORADI3, ESMAT ALEMZADEH1,4, FAHIMEH GHASEMI4,5, HAMID SALEHINIYA6, IBRAHIM ALKATOUT7,*

1 Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran
2 Department of Midwifery, Ministry of Health and Medical Education, Tehran, Iran
3 Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
4 Department of Biotechnology, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran
5 Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran
6 Social Determinants of Health Research Center, Birjand University of Medical Sciences, Birjand, Iran
7 Kiel School of Gynaecological Endoscopy, Campus Kiel, University Hospitals Schleswig-Holstein, Kiel, Germany

* Corresponding Author: IBRAHIM ALKATOUT. Email: email

Oncology Research 2024, 32(5), 831-847. https://doi.org/10.32604/or.2024.031006

Abstract

Ovarian cancer is among the most lethal gynecological cancers, primarily due to the lack of specific symptoms leading to an advanced-stage diagnosis and resistance to chemotherapy. Drug resistance (DR) poses the most significant challenge in treating patients with existing drugs. The Food and Drug Administration (FDA) has recently approved three new therapeutic drugs, including two poly (ADP-ribose) polymerase (PARP) inhibitors (olaparib and niraparib) and one vascular endothelial growth factor (VEGF) inhibitor (bevacizumab) for maintenance therapy. However, resistance to these new drugs has emerged. Therefore, understanding the mechanisms of DR and exploring new approaches to overcome them is crucial for effective management. In this review, we summarize the major molecular mechanisms of DR and discuss novel strategies to combat DR.

Keywords


Cite This Article

APA Style
ALEMZADEH, E., ALLAHQOLI, L., MAZIDIMORADI, A., ALEMZADEH, E., GHASEMI, F. et al. (2024). Deciphering resistance mechanisms and novel strategies to overcome drug resistance in ovarian cancer: a comprehensive review. Oncology Research, 32(5), 831-847. https://doi.org/10.32604/or.2024.031006
Vancouver Style
ALEMZADEH E, ALLAHQOLI L, MAZIDIMORADI A, ALEMZADEH E, GHASEMI F, SALEHINIYA H, et al. Deciphering resistance mechanisms and novel strategies to overcome drug resistance in ovarian cancer: a comprehensive review. Oncol Res. 2024;32(5):831-847 https://doi.org/10.32604/or.2024.031006
IEEE Style
E. ALEMZADEH et al., "Deciphering resistance mechanisms and novel strategies to overcome drug resistance in ovarian cancer: a comprehensive review," Oncol. Res., vol. 32, no. 5, pp. 831-847. 2024. https://doi.org/10.32604/or.2024.031006



cc This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 500

    View

  • 141

    Download

  • 0

    Like

Share Link